Vanguard Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$396M Buy
13,870,224
+994,960
+8% +$26.5M 0.24% 70
2026
Q2
$310M Buy
12,875,264
+1,450,511
+13% +$37.9M 0.21% 81
2026
Q1
$321M Buy
+11,424,753
New +$304M 0.27% 62

Other funds holding PFE

Vanguard Asset Management's PFE Position: Q3 2026 in Review

Vanguard Asset Management increased its Pfizer (PFE) stake by 7.7% in Q3 2026, buying an estimated $26.5M and bringing the position to 13,870,224 shares worth $396M. The position accounts for 0.24% of the portfolio, ranked #70.

Vanguard Asset Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,796 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vanguard Asset Management held 13,870,224 shares of Pfizer worth $396M as of Q3 2026.
  • Vanguard Asset Management bought 994,960 Pfizer shares in Q3 2026, an estimated $26.5M.
  • Pfizer made up 0.24% of Vanguard Asset Management's portfolio in Q3 2026, its #70 holding.
  • Vanguard Asset Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,796 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.